PKS VIDEO LIBRARY
<< View complete library >>
NEWS from CONSORTIUM MEMBERS
Mark your calendar for Wistar's upcoming in-depth discussion with President and CEO Dr. Dario Altieri. He will review our important cancer research progress, local and global education initiatives, and how our history and expertise in pandemic preparedness has positioned us to address today's global health threats. Please register below for this special virtual event and submit your questions via the registration page. We will respond to as many as possible during the program.
REGISTER TODAY
The event is free and open to the public. Feel free to share this invite with family or friends.
Duke-NUS Medical School, Singapore’s research-intensive, graduate-entry medical school, has joined BioStrategy Partners Inc. (BioSP), a consortium of academic institutions that collaborate with industry partners to scale academic discoveries and bring new treatments, diagnostics and other products to patients worldwide.
Other consortium members include the Children’s Hospital of Philadelphia, The Pennsylvania State University, Temple University, Thomas Jefferson University, The Wistar Institute and University of the Sciences. Duke-NUS is the consortium’s first non-US-based member.
As a member of the consortium, Duke-NUS will participate in BioSP’s Germinator program, which partners with pharmaceutical and medical device companies to identify and de-risk promising academic projects through a coordinated process, including organized sessions with industry-based scientific and commercial experts. The result is a joint development plan and funding, as well as intellectual exchanges and other forms of engagement with industry-based scientists.
“BioSP is excited to welcome into the consortium Duke-NUS, which has established a solid reputation for world-class research. Our members, industry partners and, ultimately, patients stand to benefit from the multinational perspective Duke-NUS will bring,” said Erika Swift, President of BioSP.
“Finding mechanisms to create long-term, substantive relationships with industry is a key strategy for Duke-NUS’s innovation and entrepreneurship program,” said Associate Professor Christopher Laing, Senior Associate Dean for Innovation and Entrepreneurship at Duke-NUS. “Universities are great at discovery – but we need industry partners to scale our impact. Organisations like BioSP help us to amplify our collaborative reach.”
In addition to participating in the Germinator programme, BioSP consortium members, which collectively perform more than US$1 billion of annual biomedical research and development, share best practices and expertise for commercialization, and provide shared educational resources to scientists across their institutions.
About Duke-NUS Medical School
For more information, please visit www.duke-nus.edu.sg
For media inquiries, please contact:
Michele Washko admin@biostrategypartnes.org Tel: 717-514-0436
A new study by led by Children’s Hospital of Philadelphia (CHOP) has found that neighborhood violent crime is associated with high levels of perceived stress in pregnancy. The study, published in the International Journal of Environmental Research and Public Health, also found that even though the results held up regardless of race, Black women were significantly more likely to live in neighborhoods with high levels of violent crime and were more likely to report high perceived stress than non-Black women.
<<FULL STORY>>
A team of researchers at Children’s Hospital of Philadelphia (CHOP) affiliated with the CHOP Epilepsy Neurogenetics Initiative (ENGIN) further bridged the gap between genomic information and clinical outcome data by systematically linking genetic information with electronic medical records, focusing on how genetic neurological disorders in children develop over time. The findings were published today in the journal Genetics in Medicine.
More than three-quarters of the patients in Penn State Health Milton S. Hershey Medical Center’s Cardiac Rehabilitation Program find their depression decreases, half of patients see their strength nearly doubled and 80% of patients meet their blood pressure goal of 130/80 or lower.
According to a study by The Wistar Institute, breast cancer cells starved for oxygen send out messages that induce oncogenic changes in surrounding normal epithelial cells. These messages are packaged into particles called extracellular vesicles (EVs) and reprogram mitochondrial shape and position within the recipient normal cells to ultimately promote deregulated tissue morphogenesis. These findings were published today in Developmental Cell.
Dr. Maureen Murphy, Ira Brind Professor and program leader of the Molecular & Cellular Oncogenesis Program of The Wistar Institute Cancer Center, has been investigating the importance of inherited mutations in the gene encoding p53 tumor suppressor protein to determine cancer susceptibility in people of African descent and people of Ashkenazi Jewish descent, for the past twenty-two years.
Women carrying twins are at higher risk for premature birth and miscarriage – those whose cervix dilates before 24 weeks are at highest risk – and yet one common treatment is not recommended for this population. A new multi-center randomized-controlled trial from Thomas Jefferson University shows that cerclage, an intervention that sutures a dilating cervix closed, can help prevent preterm birth and miscarriage. The findings could overturn existing guidelines.
Studies have shown that intrauterine devices (IUDs) that release progestins can help adult women with heavy menstrual bleeding, discomfort, and cramping, in addition to providing contraception. However, there are little data on whether they reduce these symptoms in younger women and adolescents, especially those with physical or intellectual disabilities. New research from the largest dataset studied to date, demonstrates that IUDs are an effective means of stopping periods or managing symptoms associated with periods in adolescents with disabilities.
Patients with obesity are at higher risk of developing heart failure. And yet, many obese patients face obstacles to getting heart transplants, as recovery is considered to be more challenging and risky in individuals with high body mass. Some physicians have attempted to pair bariatric surgery, which has shown to effectively reduce body mass in some patients, with LVAD surgery – considered a bridge to heart transplantation. However, the studies in general were too small to assess whether the approach was generalizable. New research from Jefferson pooled and analyzed data from multiple studies in a meta-analysis to assess the real-life impact of pairing the bridge-to-transplant LVAD surgery with a sleeve gastrectomy, a bariatric procedure for morbidly obese patients performed for weight reduction.
Sponsors
If you want to stay informed about BioStrategy Parterns, subscribe here.
SUBSCRIBE
bryan.tsao@biostrategypartners.org 785-656-0891
Copyright 2017, BioStrategy Partners. All rights reserved
